ESC 365 - Should we avoid transvenous defibrillator therapy?

EHRA Premium Access

Should we avoid transvenous defibrillator therapy?

Session: Defibrillator therapy without a lead in the heart

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Professor J. Healey (Hamilton, CA)

Event: EHRA 2023

Congress Presentation

About the speaker

Professor Jeff Healey

Population Health Research Institute, Hamilton (Canada)

16 presentations

1 follower

3 more presentations in this session

Has the S-ICD become standard of care?

Speaker: Professor P. Lambiase (London, GB)

Modular therapy with S-ICD and leadless pacing

Speaker: Doctor F. Tjong (Amsterdam, NL)

Does the substernal ICD meet our needs?

Speaker: Doctor N. Clementy (Montpellier, FR)

Access the full session

Defibrillator therapy without a lead in the heart

Speakers: Professor J. Healey, Professor P. Lambiase, Doctor F. Tjong, Doctor N. Clementy

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources